Stryker Sees FY23 Organic Net Sales Growth 10%-10.5%; Sees Adj. EPS $10.35-$10.45 Vs $10.36 Est
Portfolio Pulse from Benzinga Newsdesk
Stryker Corporation has projected its FY23 organic net sales growth to be between 10% and 10.5%. The company also anticipates its adjusted EPS to be in the range of $10.35 to $10.45, compared to the estimated $10.36.
November 02, 2023 | 9:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stryker's FY23 organic net sales growth is expected to be 10%-10.5%. The adjusted EPS is projected to be $10.35-$10.45, versus the $10.36 estimate.
Stryker's projected sales growth and adjusted EPS for FY23 are both positive indicators for the company's performance. The EPS projection is slightly higher than the estimate, which could lead to a positive market reaction and potential stock price increase in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100